Literature DB >> 22310989

Neuromuscular disease. A novel imaging method to quantify low levels of dystrophin in Duchenne muscular dystrophy.

Katy Malpass.   

Abstract

Entities:  

Year:  2012        PMID： 22310989     DOI： 10.1038/nrneurol.2012.15

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens.

Authors:  L E Taylor; Y J Kaminoh; C K Rodesch; K M Flanigan
Journal:  Neuropathol Appl Neurobiol       Date:  2012-10       Impact factor: 8.090
  1 in total
  2 in total

Review 1.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

2.  Correspondence: Measuring dystrophin-faster is not necessarily better.

Authors:  Virginia Arechavala-Gomeza; Lucy Feng; Jennifer E Morgan; Francesco Muntoni
Journal:  Nat Rev Neurol       Date:  2012-07-10       Impact factor: 42.937
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.